Clinical, Diagnostic and Therapeutic Approaches to Complications of Brucellosis: An Experience of 12 Years

Objective: To describe the clinical presentations, laboratory findings, prevalence and pattern of complications and the response to treatment of brucellosis in a 12-year period in a Turkish research hospital. Materials and Methods: Between 1996 and 2008, 231 patients were diagnosed with brucellosis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medical principles and practice 2012, Vol.21 (1), p.46-50
Hauptverfasser: Mermut, Gülşen, Özgenç, Onur, Avcı, Meltem, Olut, Ali Ilgın, Öktem, Ebru, Genç, Vecdi Evren, Arı, Alpay, Coskuner, Seher Ayten
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 50
container_issue 1
container_start_page 46
container_title Medical principles and practice
container_volume 21
creator Mermut, Gülşen
Özgenç, Onur
Avcı, Meltem
Olut, Ali Ilgın
Öktem, Ebru
Genç, Vecdi Evren
Arı, Alpay
Coskuner, Seher Ayten
description Objective: To describe the clinical presentations, laboratory findings, prevalence and pattern of complications and the response to treatment of brucellosis in a 12-year period in a Turkish research hospital. Materials and Methods: Between 1996 and 2008, 231 patients were diagnosed with brucellosis and treated in our clinic. Medical records of 189 of the 231 patients with at least one demonstrable complication of the disease were reviewed for anamnesis, diagnosis, complications, treatment and clinical outcomes. Results: The decreasing order of the complications was: hematological, 104 (55%); osteoarticular, 70 (37%); hepatobiliary, 59 (31%), and gastrointestinal, 23 (12%). The most common laboratory findings were anemia, lymphomonocytosis, elevated sedimentation rate and C-reactive protein, and elevated aminotransaminases. Conclusion: The hematological, osteoarticular and hepatobiliary manifestations were predominant. Bursitis, synovitis, glomerulonephritis, cutaneous lesion and deep vein thrombosis were the rare complications observed in our study. In clinical practice, brucellosis should be considered in the differential diagnosis in the presence of infrequent complications.
doi_str_mv 10.1159/000331588
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_22024559</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>908011418</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-4192cf215c42e363f6a732a6d3f3c79398a252eaa1f6d74dd29b1e507b9a1ba83</originalsourceid><addsrcrecordid>eNo9kEtPwzAQhC0E4lE4cEfIN4REwGvHTcKtlKeExKUcOEVbZ1Nc0jjYiQT_nkQtPe2u9pvRaBg7BXENoLMbIYRSoNN0hx1CLFUkQMNuvwuAKNEJHLCjEJY9liol9tmBlELGWmeHbDmtbG0NVlf83uKidqG1hmNd8NkneWyoG-5J03iH5pMCbx2fulVT9ZrWujpwV_I73xmqKhdsuOWTmj_8NOQt1YaGL0j-QejDMdsrsQp0spkj9v74MJs-R69vTy_TyWtkVCzaKIZMmlKCNrEkNVblGBMlcVyoUpkkU1mKUktChHJcJHFRyGwOpEUyzxDmmKoRu1j79pm_OwptvrJhyIc1uS7kmUj7XmIYyMs1abwLwVOZN96u0P_mIPKh2XzbbM-eb1y7-YqKLflfZQ-crYEv9AvyW2Cj_wPwNHuO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>908011418</pqid></control><display><type>article</type><title>Clinical, Diagnostic and Therapeutic Approaches to Complications of Brucellosis: An Experience of 12 Years</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Mermut, Gülşen ; Özgenç, Onur ; Avcı, Meltem ; Olut, Ali Ilgın ; Öktem, Ebru ; Genç, Vecdi Evren ; Arı, Alpay ; Coskuner, Seher Ayten</creator><creatorcontrib>Mermut, Gülşen ; Özgenç, Onur ; Avcı, Meltem ; Olut, Ali Ilgın ; Öktem, Ebru ; Genç, Vecdi Evren ; Arı, Alpay ; Coskuner, Seher Ayten</creatorcontrib><description>Objective: To describe the clinical presentations, laboratory findings, prevalence and pattern of complications and the response to treatment of brucellosis in a 12-year period in a Turkish research hospital. Materials and Methods: Between 1996 and 2008, 231 patients were diagnosed with brucellosis and treated in our clinic. Medical records of 189 of the 231 patients with at least one demonstrable complication of the disease were reviewed for anamnesis, diagnosis, complications, treatment and clinical outcomes. Results: The decreasing order of the complications was: hematological, 104 (55%); osteoarticular, 70 (37%); hepatobiliary, 59 (31%), and gastrointestinal, 23 (12%). The most common laboratory findings were anemia, lymphomonocytosis, elevated sedimentation rate and C-reactive protein, and elevated aminotransaminases. Conclusion: The hematological, osteoarticular and hepatobiliary manifestations were predominant. Bursitis, synovitis, glomerulonephritis, cutaneous lesion and deep vein thrombosis were the rare complications observed in our study. In clinical practice, brucellosis should be considered in the differential diagnosis in the presence of infrequent complications.</description><identifier>ISSN: 1011-7571</identifier><identifier>EISSN: 1423-0151</identifier><identifier>DOI: 10.1159/000331588</identifier><identifier>PMID: 22024559</identifier><language>eng</language><publisher>Basel, Switzerland</publisher><subject>Adolescent ; Adult ; Aged ; Anti-Bacterial Agents - therapeutic use ; Blood Sedimentation ; Brucellosis - complications ; Brucellosis - diagnosis ; Brucellosis - drug therapy ; C-Reactive Protein - metabolism ; Diagnosis, Differential ; Doxycycline - therapeutic use ; Female ; Gastrointestinal Diseases - diagnosis ; Gastrointestinal Diseases - drug therapy ; Gastrointestinal Diseases - epidemiology ; Gastrointestinal Diseases - microbiology ; Hematologic Diseases - diagnosis ; Hematologic Diseases - drug therapy ; Hematologic Diseases - epidemiology ; Hematologic Diseases - microbiology ; Humans ; Joint Diseases - diagnosis ; Joint Diseases - drug therapy ; Joint Diseases - epidemiology ; Joint Diseases - microbiology ; Male ; Middle Aged ; Original Paper ; Prevalence ; Retrospective Studies ; Rifampin - therapeutic use ; Streptomycin - therapeutic use ; Time Factors ; Turkey ; Young Adult</subject><ispartof>Medical principles and practice, 2012, Vol.21 (1), p.46-50</ispartof><rights>2011 S. Karger AG, Basel</rights><rights>Copyright © 2011 S. Karger AG, Basel.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-4192cf215c42e363f6a732a6d3f3c79398a252eaa1f6d74dd29b1e507b9a1ba83</citedby><cites>FETCH-LOGICAL-c340t-4192cf215c42e363f6a732a6d3f3c79398a252eaa1f6d74dd29b1e507b9a1ba83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22024559$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mermut, Gülşen</creatorcontrib><creatorcontrib>Özgenç, Onur</creatorcontrib><creatorcontrib>Avcı, Meltem</creatorcontrib><creatorcontrib>Olut, Ali Ilgın</creatorcontrib><creatorcontrib>Öktem, Ebru</creatorcontrib><creatorcontrib>Genç, Vecdi Evren</creatorcontrib><creatorcontrib>Arı, Alpay</creatorcontrib><creatorcontrib>Coskuner, Seher Ayten</creatorcontrib><title>Clinical, Diagnostic and Therapeutic Approaches to Complications of Brucellosis: An Experience of 12 Years</title><title>Medical principles and practice</title><addtitle>Med Princ Pract</addtitle><description>Objective: To describe the clinical presentations, laboratory findings, prevalence and pattern of complications and the response to treatment of brucellosis in a 12-year period in a Turkish research hospital. Materials and Methods: Between 1996 and 2008, 231 patients were diagnosed with brucellosis and treated in our clinic. Medical records of 189 of the 231 patients with at least one demonstrable complication of the disease were reviewed for anamnesis, diagnosis, complications, treatment and clinical outcomes. Results: The decreasing order of the complications was: hematological, 104 (55%); osteoarticular, 70 (37%); hepatobiliary, 59 (31%), and gastrointestinal, 23 (12%). The most common laboratory findings were anemia, lymphomonocytosis, elevated sedimentation rate and C-reactive protein, and elevated aminotransaminases. Conclusion: The hematological, osteoarticular and hepatobiliary manifestations were predominant. Bursitis, synovitis, glomerulonephritis, cutaneous lesion and deep vein thrombosis were the rare complications observed in our study. In clinical practice, brucellosis should be considered in the differential diagnosis in the presence of infrequent complications.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Blood Sedimentation</subject><subject>Brucellosis - complications</subject><subject>Brucellosis - diagnosis</subject><subject>Brucellosis - drug therapy</subject><subject>C-Reactive Protein - metabolism</subject><subject>Diagnosis, Differential</subject><subject>Doxycycline - therapeutic use</subject><subject>Female</subject><subject>Gastrointestinal Diseases - diagnosis</subject><subject>Gastrointestinal Diseases - drug therapy</subject><subject>Gastrointestinal Diseases - epidemiology</subject><subject>Gastrointestinal Diseases - microbiology</subject><subject>Hematologic Diseases - diagnosis</subject><subject>Hematologic Diseases - drug therapy</subject><subject>Hematologic Diseases - epidemiology</subject><subject>Hematologic Diseases - microbiology</subject><subject>Humans</subject><subject>Joint Diseases - diagnosis</subject><subject>Joint Diseases - drug therapy</subject><subject>Joint Diseases - epidemiology</subject><subject>Joint Diseases - microbiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original Paper</subject><subject>Prevalence</subject><subject>Retrospective Studies</subject><subject>Rifampin - therapeutic use</subject><subject>Streptomycin - therapeutic use</subject><subject>Time Factors</subject><subject>Turkey</subject><subject>Young Adult</subject><issn>1011-7571</issn><issn>1423-0151</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtPwzAQhC0E4lE4cEfIN4REwGvHTcKtlKeExKUcOEVbZ1Nc0jjYiQT_nkQtPe2u9pvRaBg7BXENoLMbIYRSoNN0hx1CLFUkQMNuvwuAKNEJHLCjEJY9liol9tmBlELGWmeHbDmtbG0NVlf83uKidqG1hmNd8NkneWyoG-5J03iH5pMCbx2fulVT9ZrWujpwV_I73xmqKhdsuOWTmj_8NOQt1YaGL0j-QejDMdsrsQp0spkj9v74MJs-R69vTy_TyWtkVCzaKIZMmlKCNrEkNVblGBMlcVyoUpkkU1mKUktChHJcJHFRyGwOpEUyzxDmmKoRu1j79pm_OwptvrJhyIc1uS7kmUj7XmIYyMs1abwLwVOZN96u0P_mIPKh2XzbbM-eb1y7-YqKLflfZQ-crYEv9AvyW2Cj_wPwNHuO</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>Mermut, Gülşen</creator><creator>Özgenç, Onur</creator><creator>Avcı, Meltem</creator><creator>Olut, Ali Ilgın</creator><creator>Öktem, Ebru</creator><creator>Genç, Vecdi Evren</creator><creator>Arı, Alpay</creator><creator>Coskuner, Seher Ayten</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2012</creationdate><title>Clinical, Diagnostic and Therapeutic Approaches to Complications of Brucellosis: An Experience of 12 Years</title><author>Mermut, Gülşen ; Özgenç, Onur ; Avcı, Meltem ; Olut, Ali Ilgın ; Öktem, Ebru ; Genç, Vecdi Evren ; Arı, Alpay ; Coskuner, Seher Ayten</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-4192cf215c42e363f6a732a6d3f3c79398a252eaa1f6d74dd29b1e507b9a1ba83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Blood Sedimentation</topic><topic>Brucellosis - complications</topic><topic>Brucellosis - diagnosis</topic><topic>Brucellosis - drug therapy</topic><topic>C-Reactive Protein - metabolism</topic><topic>Diagnosis, Differential</topic><topic>Doxycycline - therapeutic use</topic><topic>Female</topic><topic>Gastrointestinal Diseases - diagnosis</topic><topic>Gastrointestinal Diseases - drug therapy</topic><topic>Gastrointestinal Diseases - epidemiology</topic><topic>Gastrointestinal Diseases - microbiology</topic><topic>Hematologic Diseases - diagnosis</topic><topic>Hematologic Diseases - drug therapy</topic><topic>Hematologic Diseases - epidemiology</topic><topic>Hematologic Diseases - microbiology</topic><topic>Humans</topic><topic>Joint Diseases - diagnosis</topic><topic>Joint Diseases - drug therapy</topic><topic>Joint Diseases - epidemiology</topic><topic>Joint Diseases - microbiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original Paper</topic><topic>Prevalence</topic><topic>Retrospective Studies</topic><topic>Rifampin - therapeutic use</topic><topic>Streptomycin - therapeutic use</topic><topic>Time Factors</topic><topic>Turkey</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mermut, Gülşen</creatorcontrib><creatorcontrib>Özgenç, Onur</creatorcontrib><creatorcontrib>Avcı, Meltem</creatorcontrib><creatorcontrib>Olut, Ali Ilgın</creatorcontrib><creatorcontrib>Öktem, Ebru</creatorcontrib><creatorcontrib>Genç, Vecdi Evren</creatorcontrib><creatorcontrib>Arı, Alpay</creatorcontrib><creatorcontrib>Coskuner, Seher Ayten</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical principles and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mermut, Gülşen</au><au>Özgenç, Onur</au><au>Avcı, Meltem</au><au>Olut, Ali Ilgın</au><au>Öktem, Ebru</au><au>Genç, Vecdi Evren</au><au>Arı, Alpay</au><au>Coskuner, Seher Ayten</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical, Diagnostic and Therapeutic Approaches to Complications of Brucellosis: An Experience of 12 Years</atitle><jtitle>Medical principles and practice</jtitle><addtitle>Med Princ Pract</addtitle><date>2012</date><risdate>2012</risdate><volume>21</volume><issue>1</issue><spage>46</spage><epage>50</epage><pages>46-50</pages><issn>1011-7571</issn><eissn>1423-0151</eissn><abstract>Objective: To describe the clinical presentations, laboratory findings, prevalence and pattern of complications and the response to treatment of brucellosis in a 12-year period in a Turkish research hospital. Materials and Methods: Between 1996 and 2008, 231 patients were diagnosed with brucellosis and treated in our clinic. Medical records of 189 of the 231 patients with at least one demonstrable complication of the disease were reviewed for anamnesis, diagnosis, complications, treatment and clinical outcomes. Results: The decreasing order of the complications was: hematological, 104 (55%); osteoarticular, 70 (37%); hepatobiliary, 59 (31%), and gastrointestinal, 23 (12%). The most common laboratory findings were anemia, lymphomonocytosis, elevated sedimentation rate and C-reactive protein, and elevated aminotransaminases. Conclusion: The hematological, osteoarticular and hepatobiliary manifestations were predominant. Bursitis, synovitis, glomerulonephritis, cutaneous lesion and deep vein thrombosis were the rare complications observed in our study. In clinical practice, brucellosis should be considered in the differential diagnosis in the presence of infrequent complications.</abstract><cop>Basel, Switzerland</cop><pmid>22024559</pmid><doi>10.1159/000331588</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1011-7571
ispartof Medical principles and practice, 2012, Vol.21 (1), p.46-50
issn 1011-7571
1423-0151
language eng
recordid cdi_pubmed_primary_22024559
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Adolescent
Adult
Aged
Anti-Bacterial Agents - therapeutic use
Blood Sedimentation
Brucellosis - complications
Brucellosis - diagnosis
Brucellosis - drug therapy
C-Reactive Protein - metabolism
Diagnosis, Differential
Doxycycline - therapeutic use
Female
Gastrointestinal Diseases - diagnosis
Gastrointestinal Diseases - drug therapy
Gastrointestinal Diseases - epidemiology
Gastrointestinal Diseases - microbiology
Hematologic Diseases - diagnosis
Hematologic Diseases - drug therapy
Hematologic Diseases - epidemiology
Hematologic Diseases - microbiology
Humans
Joint Diseases - diagnosis
Joint Diseases - drug therapy
Joint Diseases - epidemiology
Joint Diseases - microbiology
Male
Middle Aged
Original Paper
Prevalence
Retrospective Studies
Rifampin - therapeutic use
Streptomycin - therapeutic use
Time Factors
Turkey
Young Adult
title Clinical, Diagnostic and Therapeutic Approaches to Complications of Brucellosis: An Experience of 12 Years
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T22%3A01%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical,%20Diagnostic%20and%20Therapeutic%20Approaches%20to%20Complications%20of%20Brucellosis:%20An%20Experience%20of%2012%20Years&rft.jtitle=Medical%20principles%20and%20practice&rft.au=Mermut,%20G%C3%BCl%C5%9Fen&rft.date=2012&rft.volume=21&rft.issue=1&rft.spage=46&rft.epage=50&rft.pages=46-50&rft.issn=1011-7571&rft.eissn=1423-0151&rft_id=info:doi/10.1159/000331588&rft_dat=%3Cproquest_pubme%3E908011418%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=908011418&rft_id=info:pmid/22024559&rfr_iscdi=true